Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has shared an announcement.
Neuroscientific Biopharmaceuticals Ltd announced the cessation of 3,000,000 options that were set to expire on December 7, 2024, without being exercised or converted. This update on the company’s issued capital reflects a strategic adjustment, potentially impacting stakeholders’ perceptions of the company’s financial maneuvers and its future securities management.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd operates in the biopharmaceutical industry, focusing on the development of novel drugs aimed at treating neurological disorders. The company is dedicated to innovative research with a specific market focus on addressing unmet medical needs in neuroscience.
YTD Price Performance: 26.67%
Average Trading Volume: 131,973
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.49M
See more insights into NSB stock on TipRanks’ Stock Analysis page.